- World TB Day Key Messages and Resources Document
- World TB Day Social Media Examples
- World TB Thunderclap
- U.S. World TB Day Poster
In preparing for World TB Day on March 24, the Centers for Disease Control and Prevention’s Division of Tuberculosis Elimination (CDC/DTBE) is pleased to announce additional 2017 World TB Day communication messages and materials that are now available on their website. Materials include:
"Culture of Collaboration" is the theme for the 2017 NTCA National TB Conference. This conference is an annual forum that brings state, local, territorial, and other TB control professionals together to discuss a wide array of clinical, technical, policy, and programmatic TB issues.
This conference will be held on April 18-21 in Atlanta, Georgia, with special meetings on April 18, and post-meetings in the afternoon on Friday, April 21.
Some key topics include:
View Draft Agenda
Topic: The Mycobacteriology Laboratory: Tests, Results, and Clinical Implications
Date: March 17, 2017
Time: 12:00 noon (Central Daylight Time)
A free webinar (400 seats) is being offered by the National TB Nurse Coalition, the nursing section of the National TB Controllers Association (NTCA). 1.2 CEUs are available for nurses. Speakers include:
Registration URL: https://www.pathlms.com/tbcontrollers/courses/4259
On February 27 and 28, a Round Robin was hosted by the Curry International Tuberculosis Center in Oakland, California. All five RTMCCs, along with representatives from the CDC were present. Dr. Temesgen and Jennifer Curran attended from the Mayo Center for Tuberculosis.
Johns Hopkins University and the Medicines Patient Pool (MPP) have signed a license agreement to facilitate the clinical development of the tuberculosis drug, sutezolid. Sutezolid, an oxazolidinone antibiotic in the same class as linezolid, has shown promise in use as a compound in early stage trials to be more potent and less toxic in the treatment of TB.
The CDC has recently published Modules 6 and 8 of the Self-Study Modules in Spanish. These Self-Study Modules on Tuberculosis are a series of educational modules designed to provide information about TB in a self-study format. The series consists of a total of nine modules that are separated into two courses. The first course, Modules 1-5, provides basic information on TB. The second course, Modules 6-9, provides more specific TB programmatic information.
Jointly sponsored by the Regional Training and Medical Consultation Centers, the course "Optimizing Outcomes of Drug-Resistant Tuberculosis in High-Resource, Low-Incidence Settings" will be offered as part of The Union-NAR End TB 2017 Conference in Vancouver, Canada.
This 3-hour training will provide an overview of the medical management and case management of drug-resistant tuberculosis including a discussion of diagnostics, treatment options, special situations, and a panel discussion with clinical and programmatic perspectives on the use of the short course MDR regimen in high-resource, low-incidence settings.
Location: Sheraton Vancouver Wall Centre
Date: February 22
Time: 12:00 p.m. - 3:00 p.m.
In an effort to accelerate progress towards ending TB, WHO’s Global TB Programme (GTB) has established the first Global TB Research Task Force.
The Task Force, comprising of 19 TB programme, research financing, technical, civil society and academic experts, chaired by Christine Sizemore, NIH/NIAID, met in Geneva from 8-9 December 2016. The goal was to identify strategies for WHO to promote and facilitate TB research, and speed-up translation of science ‘from bench to bedside’ to improve TB care and control at international and national levels. Drawing on both global and national research needs, the Task Force also advised on actions to address global funding for TB research and development in congruence with current global and national efforts.
The Centers for Disease Control and Prevention’s Division of Tuberculosis Elimination (DTBE) has partnered with Medscape, a leading online resource for physicians and healthcare professionals, to produce an expert video commentary featuring DTBE Director, Dr. Philip LoBue. The video provides information for physicians on the new U.S. Preventive Services Task Force recommendation for latent TB infection testing. Dr. LoBue discusses diagnosis and treatment guidelines, as well as available DTBE resources on latent TB infection.
The video is a great way to share information with private healthcare providers on the importance of latent TB infection testing and treatment. You can find the video online: http://www.medscape.com/viewarticle/873121?src=par_cdc_stm_mscpedt&faf=1
The World Health Organization (WHO) welcomes the United Nations (UN) General Assembly (GA) Resolution A/71/L.41 passed today, calling for the UNGA to hold the first-ever high-level meeting on the fight against tuberculosis (TB) in 2018.
WHO has been asked to work with the UN Secretary-General, in consultation with Member States, to conceptualize and plan the 2018 high-level meeting. The resolution also highlights the WHO Global Ministerial Conference on the fight against TB in the context of public health Sustainable Development Goals, which will be hosted by the Russian Federation in Moscow on 16-17 November 2017.
“This is a tremendous and unprecedented step forward by governments and all partners engaged in the fight against TB”, said Dr Mario Raviglione, Director of the WHO Global TB Programme. “The Ministerial Conference and the UNGA high-level meeting will be fundamental to drive efforts to end this top infectious killer. We look forward to working closely with the Office of the UN Secretary-General, in consultation with Member States, to ensure the meeting results in bold and innovative solutions. For that, the engagement of all partners will be crucial for the success of these meetings.”
WHO in its report this year announced that TB was one of the top 10 causes of death worldwide in 2015, responsible for more deaths than HIV and malaria. In the same year, an estimated 1.8 million people died from TB, of which 0.4 million were co-infected with HIV. Worldwide, 10.4 million people fell ill with TB. The report highlighted the need for countries to move much faster to prevent, detect, and treat the disease if they are to meet global targets.
World Health Organization
Global TB Programme
20, Avenue Appia, CH-1211,Geneva, Switzerland
Tel: (+41) 22 791 4695, Email: firstname.lastname@example.org
For more information please go to www.who.int/tb